Search Results - "Ojeda, Belen"

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort by Gianni, Luca, Dr, Eiermann, Wolfgang, MD, Semiglazov, Vladimir, MD, Lluch, Ana, PhD, Tjulandin, Sergei, MD, Zambetti, Milvia, MD, Moliterni, Angela, MD, Vazquez, Federico, MD, Byakhov, Mikhail J, PhD, Lichinitser, Mikhail, MD, Climent, Miguel Angel, MD, Ciruelos, Eva, MD, Ojeda, Belen, MD, Mansutti, Mauro, MD, Bozhok, Alla, PhD, Magazzù, Domenico, PhD, Heinzmann, Dominik, PhD, Steinseifer, Jutta, PhD, Valagussa, Pinuccia, BS, Baselga, Jose, MD

“…Summary Background In our randomised, controlled, phase 3 trial NeOAdjuvant Herceptin (NOAH) trial in women with HER2-positive locally advanced or inflammatory…”
Get full text

Untapped Potential of Citizen Science in Mexican Small-Scale Fisheries by Fulton, Stuart, López-Sagástegui, Catalina, Weaver, Amy Hudson, Fitzmaurice-Cahluni, Fernanda, Galindo, Carlos, Fernández-Rivera Melo, Francisco, Yee, Silvia, Ojeda-Villegas, María Belén, Fuentes, David Antonio, Torres-Bahena, Elizabeth

“…Citizen science is a rapidly growing field with well-designed and run citizen science projects providing substantial benefits for conservation and management…”
Get full text

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort by Gianni, Luca, Dr, Eiermann, Wolfgang, MD, Semiglazov, Vladimir, MD, Manikhas, Alexey, MD, Lluch, Ana, MD, Tjulandin, Sergey, MD, Zambetti, Milvia, MD, Vazquez, Federico, MD, Byakhow, Mikhail, MD, Lichinitser, Mikhail, MD, Climent, Miguel Angel, MD, Ciruelos, Eva, MD, Ojeda, Belén, MD, Mansutti, Mauro, MD, Bozhok, Alla, MD, Baronio, Roberta, MSci, Feyereislova, Andrea, MD, Barton, Claire, MD, Valagussa, Pinuccia, Baselga, Jose, MD

“…Summary Background The monoclonal antibody trastuzumab has survival benefit when given with chemotherapy to patients with early, operable, and metastatic…”
Get full text

Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer by BASELGA, José, MARTINS SEGALLA, José Getúlio, LLOMBART, Antonio, GARICOCHEA, Bernardo, CLIMENT DURAN, Miguel Angel, GEHM HOFF, Paulo Marcelo, ESPIE, Marc, GEMEINDER DE MORAES, Andre Augusto, ALBUQUERQUE RIBEIRO, Ronaldo, MATHIAS, Clarissa, GIL GIL, Miguel, OJEDA, Belén, ROCHE, Henri, MORALES, Josefa, KWON RO, Sunhee, LI, Shell, COSTA, Frederico, DEL GIGLIO, Auro, PINCZOWSKI, Hélio, CIRUELOS, Eva M, CABRAL FILHO, Sebastião, GOMEZ, Patricia, VAN EYLL, Brigitte, BERMEJO, Begoña

“…Sorafenib is a multikinase inhibitor with antiangiogenic/antiproliferative activity. A randomized, double-blind, placebo-controlled phase IIB trial assessed…”
Get full text

Mismatch Repair Deficiency in Ovarian Carcinoma: Frequency, Causes, and Consequences by Leskela, Susanna, Romero, Ignacio, Cristobal, Eva, Pérez-Mies, Belén, Rosa-Rosa, Juan M., Gutierrez-Pecharroman, Ana, Caniego-Casas, Tamara, Santón, Almudena, Ojeda, Belén, López-Reig, Raquel, Palacios-Berraquero, María L., García, Ángel, Ibarra, Javier, Hakim, Sofía, Guarch, Rosa, López-Guerrero, José A., Poveda, Andrés, Palacios, José

“…Mismatch repair deficiency (MMRD) is involved in the initiation of both hereditary and sporadic tumors. MMRD has been extensively studied in colorectal cancer…”
Get full text

Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification by Leskela, Susanna, Romero, Ignacio, Rosa-Rosa, Juan M., Caniego-Casas, Tamara, Cristobal, Eva, Pérez-Mies, Belén, Gutierrez-Pecharroman, Ana, Santón, Almudena, Ojeda, Belén, López-Reig, Raquel, Palacios-Berraquero, María L., Andrada, Encarna, Montes, Santiago, Pastor, Francisco, Gomez, Maria C., López-Guerrero, José A., Poveda, Andrés, Palacios, José

“…Endometrioid ovarian carcinoma (EOC) has clinical and biological differences compared with other histologic types of ovarian carcinomas, but it shares…”
Get full text

Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab plus chemotherapy for platinum-resistant recurrent ovarian cancer by Husain, Amreen, Wang, Yan, Hanker, Lars C, Ojeda, Belén, Anttila, Maarit, Breda, Enrico, Vuylsteke, Peter, Pujade-Lauraine, Eric

“…Abstract Objective The randomized, open-label, phase 3 Avastin® Use in Platinum-Resistant Epithelial Ovarian Cancer (AURELIA) trial achieved its primary…”
Get full text

Water Deficit Improves Reproductive Fitness in Nicotiana benthamiana Plants Infected by Cucumber mosaic virus by Moreno, Marina, Ojeda, Belén, Hernández-Walias, Francisco J, Sanz-García, Eugenio, Canto, Tomás, Tenllado, Francisco

“…Plants are concurrently exposed to biotic and abiotic stresses, including infection by viruses and drought. Combined stresses result in plant responses that…”
Get full text

Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study by Cortes, Javier, Di Cosimo, Serena, Climent, Miguel A, Cortés-Funes, Hernán, Lluch, Ana, Gascón, Pere, Mayordomo, José I, Gil, Miguel, Benavides, Manuel, Cirera, Lluís, Ojeda, Belén, Rodríguez, César A, Trigo, José M, Vazquez, Josep, Regueiro, Pilar, Dorado, Juan F, Baselga, José

“…Purpose: To determine the recommended dose, cardiac safety, and antitumor activity of nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and the…”
Get full text

Unique or high resolution consultation as an efficiency alternative to conventional hospital outpatients consultations by Zambrana García, José Luis, Jiménez-Ojeda, Belén, Marín Patón, Mariano, Almazán González, Sagrario

Get more information

Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas) by Lerma, Enrique, Peiro, Gloria, Ramón, Teresa, Fernandez, Sonia, Martinez, Daniel, Pons, Cristina, Muñoz, Fina, Sabate, Josep Ma, Alonso, Carmen, Ojeda, Belén, Prat, Jaime, Barnadas, Agustí

“…Basal breast carcinomas triple negative for estrogen receptors, progesterone receptors and Her2/neu breast carcinomas are more aggressive than conventional…”
Get full text

Chromosome 17 Centromere Duplication and Responsiveness to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer by Tibau, Ariadna, López-Vilaró, Laura, Pérez-Olabarria, Maitane, Vázquez, Tania, Pons, Cristina, Gich, Ignasi, Alonso, Carmen, Ojeda, Belén, Ramón y Cajal, Teresa, Lerma, Enrique, Barnadas, Agustí, Escuin, Daniel

“…Abstract Human epidermal growth factor receptor 2 ( HER2 ) and topoisomerase II alpha ( TOP2A ) genes have been proposed as predictive biomarkers of…”
Get full text

OSSEOUS METAPLASIA OF THE CERVIX AS A CAUSE OF SECONDARY INFERTILITY: A CASE REPORT by Isa, Laura, Inza, Roberto, Ojeda, Belen Garcia, Zappacosta Villarroel, María Pía, Yuri, Mónica, Viglierchio, Maria Inés

Get full text

NOBODY SPEAKS ABOUT THIS: FERTILITY TREATMENTS AND ITS IMPACT ON COUPLES SEXUALITY by Ojeda, Belen Garcia, Zappacosta Villarroel, María Pía, Isa, Laura, Florencia, Poch, Argibay, Sofia Garcia, José Del Campo, María

Get full text

Should the diagnostic and therapeutic protocols for adrenal incidentalomas be changed? by Mateo-Gavira, Isabel, Vilchez-López, Francisco Javier, Larrán-Escandón, Laura, Ojeda-Schuldt, María Belén, Tinoco, Cristina López, Aguilar-Diosdado, Manuel

“…The prevalence of adrenal incidentalomas is increasing with the aging of the population and the use of high resolution imaging technics. Current protocols…”
Get more information

IS IT POSSIBLE TO PREDICT THE RESULT FOR THE TUNEL ASSAY FROM A ROUTINE SPERMOGRAM ANALYSIS? by De Caro, Roxana Vanina, Zappacosta Villarroel, María Pía, Ojeda, Belen Garcia, Guidobono, Mercedes Leticia, Osés, Raymond Joseph, Kenny, Alberto, Inza, Roberto

Get full text

A phase II trial of fixed-dosed rate gemcitabine in platinum-resistant ovarian cancer: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) Trial by Ojeda Gonzalez, Belen, Gonzalez Martin, Antonio, Bover Barcelo, Isabel, Fabregat i Mayol, Xavier, Mellado, Begoña, Rubio Perez, María Jesus, Alonso Carrion, Lorenzo, Casado Herraez, Antonio, Calvo Garcia, Elisa, Churruca Galaz, Cristina, Arcusa Lanza, Angels, Herrero Ibañez, Ana, Adrover Cebrian, Encarna, Poveda Velasco, Andres

“…Gemcitabine has well-recognized activity in the treatment of ovarian cancer. Fixed-dose rate (FDR) delivery has been proposed as a more rationale way to…”
Get full text

Circulating HER2 Extracellular Domain and Resistance to Chemotherapy in Advanced Breast Cancer by COLOMER, R, MONTERO, S, LLUCH, A, OJEDA, B, BARNADAS, A, CASADO, A, MASSUTI, B, CORTES-FUNES, H, LLOVERAS, B

“…To test the hypothesis of an association between HER2 and chemotherapy resistance, we performed a prospective assessment of the predictive value of the…”
Get full text

CD8 + TILs in early stage epithelial ovarian cancer: A GEICO study by Romero, Ignacio, Leskella, Susanna, Redondo, Andres, Gutierrez-Pecharroman, Ana, Santaballa, Ana, Cristobal Lana, Eva Maria, Calvo, Elisa, Rosa-Rosa, Juan Manuel, Oaknin, Ana, Bover, Isabel, Herrero, Ana, Sanchez-Heras, Ana Beatriz, Churruca, Cristina Maria, De Juan, Ana, Mendiola, Cesar, Romeo, Margarita, Ojeda, Belen, Lopez-Guerrero, Jose Antonio, Palacios, José, Poveda, Andres

“…Abstract only 5543 Background: The extent of tumor infiltrating lymphocytes (TILs) has emerged as a potential clinical useful biomarker in epithelial ovarian…”
Get full text

Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab (BV) plus chemotherapy (CT) for platinum (PT)-resistant recurrent ovarian cancer (OC) by Husain, Amreen, Wang, Yan V., Frederiksen, Rikke, Bollag, David T., Hanker, Lars Christian, Ojeda, Belen, Anttila, Maarit, Breda, Enrico, Vuylsteke, Peter, Pujade-Lauraine, Eric

“…Abstract only…”
Get full text